EBS · Company research
Emergent Biosolutions, Inc. (EBS): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 7.07 | $387,590,000 | 227290000.00 | 98.0000000000000000 | — | — | 2.4829596412556054 | 0.74094819346205314471 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.